Skip to main content
logo
China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.7691
-0.0245 (-3.09%)
Jun 1, 2026, 4:00 PM EDT - Market closed

China Pharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.994.144.537.018.19.64
Revenue Growth (YoY)
-7.07%-8.49%-35.41%-13.48%-15.95%-11.27%
Cost of Revenue
3.74.286.517.298.69.29
Gross Profit
0.29-0.13-1.99-0.28-0.490.35
Selling, General & Admin
3.552.832.312.252.963.15
Research & Development
0.340.280.280.240.190.32
Other Operating Expenses
-0-00.01-0.02-0.09-0.26
Total Operating Expenses
3.893.112.62.473.063.21
Operating Income
-3.6-3.24-4.59-2.75-3.55-2.86
Interest Income
000.010.010.010
Interest Expense
-0.1-0.1-0.15-0.33-0.43-0.54
Other Non-Operating Income (Expense)
0.150.15----
Total Non-Operating Income (Expense)
0.050.05-0.15-0.33-0.42-0.54
Pretax Income
-3.55-3.19-4.74-3.08-3.97-3.4
Net Income
-3.55-3.19-4.74-3.08-3.97-3.4
Net Income to Common
-3.55-3.19-4.74-3.08-3.97-3.4
Shares Outstanding (Basic)
1042000
Shares Outstanding (Diluted)
1042000
Shares Change (YoY)
343.19%145.73%416.13%221.82%13.96%5.75%
EPS (Basic)
-0.54-0.74-2.71-9.10-37.80-37.00
EPS (Diluted)
-0.54-0.74-2.71-9.10-37.80-37.00
Shares Outstanding
40.5215.523.261.060.150.09
Free Cash Flow
0.150.09-0.44-0.71-0.81-0.69
Free Cash Flow Growth
68.42%-----
Free Cash Flow Per Share
0.020.02-0.25-2.10-7.72-7.46
Gross Margin
7.26%-3.18%-43.84%-4.01%-6.09%3.62%
Operating Margin
-90.13%-78.16%-101.32%-39.25%-43.79%-29.67%
Profit Margin
-88.82%-76.91%-104.58%-43.91%-49.02%-35.26%
FCF Margin
3.75%2.15%-9.81%-10.14%-10.01%-7.13%
EBITDA
-1.44-1.66-1.910-0.850.23
EBITDA Margin
-36.15%-40.05%-42.21%0.03%-10.47%2.36%
EBIT
-3.6-3.24-4.59-2.75-3.55-2.86
EBIT Margin
-90.13%-78.16%-101.32%-39.25%-43.79%-29.67%
SEC Filings: 10-K · 10-Q